Executive Summary
This overnight filing cycle reveals a market bifurcated between aggressive corporate transformation and persistent financial distress. The most significant theme is a wave of high-value M&A and strategic investments, including AAR Corp's $4.0 billion acquisition of MRO Holdings, Summit Therapeutics' $2.0 billion partnership with AstraZeneca, and Sangoma Technologies' $204 million take-private.
These deals signal strong conviction in aerospace, biotech, and enterprise tech sectors. Conversely, the materials and energy sectors show a stark contrast: Uranium Energy Corp is executing a successful turnaround with surging production and a strong balance sheet, while Westlake Corp is shuttering a major European PVC plant, incurring $205 million in charges. Financial health is a key differentiator; companies like UEC and AAR are leveraging strong balance sheets for growth, while distressed entities like Bakhu Holdings, VIP Play, and Singularity Future Technology are filing late reports with worsening deficits and near-zero cash positions. Insider activity is limited but notable, with a director at C1 Fund making a small open-market purchase, offering a faint positive signal in an otherwise quiet period for management transactions. The digest is dominated by capital allocation events (M&A, buybacks, dividends) and regulatory filings, with a clear undercurrent of companies either scaling up aggressively or facing existential liquidity challenges.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Schedule 13G · Form 4 · 8-K · Schedule 13D · DEF 14A · S-1 · 10-K · 10-Q · 425
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from September 28, 2026.
Investment Signals (11)
- AAR Corp ↓ (BULLISH)▲
Acquiring 65% of MRO Holdings at a $4.0B enterprise value, expected to expand EBITDA margins from ~12% to 16%+ immediately, with a target of 19-20% in 3-4 years. The deal adds $1B+ in revenue from blue-chip US airlines.
- Summit Therapeutics ↓ (BULLISH)▲
Secured a $2.0B strategic investment from AstraZeneca at an $18.36/share premium, validating its ivonescimab platform. The partnership includes a clinical trial collaboration, de-risking the pipeline and providing a massive cash runway.
- Uranium Energy Corp ↓ (BULLISH)▲
Q4 production surged 157% QoQ to 82,744 pounds, while total cost per pound dropped 33% to $36.54. The unhedged sales strategy delivered a peer-leading realized price of $93.13/lb. The company has zero debt and $495M cash.
- ChipMOS Technologies ↓ (BULLISH)▲
August 2026 revenue grew 33.3% YoY and Q2 2026 net profit surged 267.4% YoY, indicating strong operational momentum in the semiconductor back-end services sector.
- HUTCHMED ↓ (BULLISH)▲
Submitted a US NDA for ORPATHYS (savolitinib) in MET-driven EGFR-mutated lung cancer, a key regulatory milestone that could unlock a significant new market opportunity.
- Sangoma Technologies ↓ (BULLISH)▲
Entered a definitive agreement to be acquired for ~$204M (C$289M) in an all-cash transaction, offering immediate and certain value to shareholders.
- C1 Fund Inc. ↓ (BULLISH)▲
Chief Investment Officer Han Elliot Jin made an open-market purchase of 5,000 shares at $4.81 (~$24.1K), a positive signal from an insider willing to deploy personal capital.
- Sumitomo Mitsui Financial Group ↓ (BULLISH)▲
FY2026 net profit rose 15.9% YoY to ¥88,933M, with operating revenue up 11.4%. The establishment of a new holding company structure on Oct 1, 2026, signals strategic reorganization.
- Orion Digital Corp (fka Mogo Inc.) (BULLISH)▲
Regained compliance with Nasdaq's minimum bid price requirement, removing a significant overhang and delisting risk.
- Copart Inc ↓ (BEARISH)▲
FY2026 total service revenues were essentially flat YoY, and net income margin slipped to 32% from 33%. Cash position fell sharply by 31.4%, suggesting a capital-intensive period or strategic reinvestment.
- VIP Play, Inc. ↓ (BEARISH)▲
FY2026 net loss improved to -$9.5M from -$19.2M, but the company has a deeply negative equity of -$39.9M and zero cash reserves for users, suggesting a cessation of core operations.
Risk Flags (8)
- Westlake Corp / Restructuring↓ [HIGH RISK]▼
Announced the closure of its PVC plant in Cologne, Germany, with total pre-tax charges of ~$205M and a workforce reduction of 120 employees. This signals significant operational headwinds in its European chemicals business.
- Bakhu Holdings / Liquidity Crisis↓ [HIGH RISK]▼
Cash and cash equivalents fell to a mere $2,041 from $25,461, with total liabilities of $11.8M against no revenue. The company is burning cash and faces imminent insolvency risk.
- VIP Play, Inc. / Going Concern↓ [HIGH RISK]▼
Despite a narrower net loss, the company's accumulated deficit hit -$72.6M, with a negative equity of -$39.9M and zero cash reserves for users. This financial profile is unsustainable.
- Singularity Future Technology / Late Filing↓ [MODERATE RISK]▼
Filed an NT 10-K for FY2026, citing an inability to finalize financial statements. While no significant change in results is anticipated, late filings are a classic red flag for internal control issues or financial distress.
- Nova Minerals / Late Filing↓ [MODERATE RISK]▼
Filed an NT 10-K for FY2026, needing more time to finalize data after a redomicile to the US. While the reason is operational, the delay introduces uncertainty around its first filing as a US entity.
- Copart Inc / Stalled Growth & Cash Burn↓ [MODERATE RISK]▼
FY2026 service revenues were flat YoY, and cash holdings dropped 31.4% to $1.9B. This combination of stagnant top-line growth and significant cash consumption is a concern for a mature business.
- WeShop Holdings / Going Concern Risk↓ [HIGH RISK]▼
The F-1 filing reveals an accumulated deficit of -£153M and total indebtedness of £2.77M against only £210K in cash. The company explicitly states it needs substantial additional financing to continue as a going concern.
- Quartzsea Acquisition Corp / SPAC Liquidation Risk↓ [MODERATE RISK]▼
If shareholders do not approve the extension to its business combination deadline (Oct 19, 2026), the SPAC will liquidate. The current share price ($10.64) is below the estimated redemption price ($10.84), suggesting market skepticism.
Opportunities (8)
- AAR Corp / Post-Merger Synergy Play↓ (OPPORTUNITY)◆
The MRO Holdings acquisition is immediately accretive to margins. With a target of 19-20% EBITDA margins within 3-4 years and a plan to deleverage to 2.0-2.5x, the stock could re-rate significantly as synergies materialize.
- Uranium Energy Corp / Unhedged Uranium Leverage↓ (OPPORTUNITY)◆
With zero debt, $495M cash, and a strategic decision to hold most inventory, UEC offers pure-play leverage to rising uranium prices. The 157% QoQ production surge and 33% cost reduction demonstrate operational execution.
- Summit Therapeutics / AstraZeneca Validation↓ (OPPORTUNITY)◆
The $2.0B investment from AZN at a premium provides a massive cash runway and strong validation for ivonescimab. The upcoming ESMO 2026 data presentation for the gastric cancer trial is a near-term catalyst.
- HUTCHMED / NDA Catalyst↓ (OPPORTUNITY)◆
The US NDA submission for savolitinib in a specific lung cancer population is a major regulatory milestone. Approval would open a large, underserved market and significantly de-risk the pipeline.
- ChipMOS Technologies / Growth Momentum↓ (OPPORTUNITY)◆
With revenue up 33% YoY and net profit surging 117% in August, the company is executing well in a cyclical upturn. This momentum could continue, making it an attractive play in the semiconductor space.
- Futurewave Acquisition Corp / SPAC Arbitrage↓ (OPPORTUNITY)◆
The merger with Olympian Group at a $400M valuation provides a clear target for the SPAC. The $10.00/share value for Olympian shareholders creates a potential floor, though execution risk remains.
- VerifyMe / Merger Arbitrage↓ (OPPORTUNITY)◆
Stockholder approval for the merger with Open World was obtained on Sept 24. The deal is progressing, and the filing of pro forma financials suggests closing conditions are being met, creating a potential arbitrage opportunity.
- C1 Fund Inc. / Insider Conviction↓ (OPPORTUNITY)◆
The open-market purchase by the CIO, even for a modest amount, is a positive signal in a filing set otherwise devoid of insider buying. It suggests management sees value at current levels.
Sector Themes (6)
- Aerospace & Defense Consolidation◆
AAR Corp's $4.0B acquisition of MRO Holdings is a transformative deal that signals a wave of consolidation in the aftermarket services sector. The focus on expanding margins and gaining scale with blue-chip US airlines is a key theme.
- Biotech Mega-Deals & Validation◆
The $2.0B investment from AstraZeneca into Summit Therapeutics is a landmark deal that validates the ivonescimab platform and signals big pharma's appetite for novel oncology assets. This could lead to a re-rating of other high-quality biotech platforms.
- Energy Transition Divergence◆
The filings show a clear divergence within the energy transition. Uranium Energy Corp is thriving as a low-cost, debt-free producer benefiting from nuclear energy demand, while Westlake Corp is retreating from European chemical markets, highlighting the uneven nature of the transition.
- Financial Distress in Micro-Caps◆
A cluster of micro-cap companies (Bakhu Holdings, VIP Play, Singularity Future Technology, WeShop Holdings) are exhibiting classic signs of distress: late filings, negative equity, near-zero cash, and going concern warnings. This underscores the high-risk nature of the micro-cap space.
- SPAC Activity Resurgence◆
Multiple SPAC-related filings (Quartzsea, Futurewave, Westin Acquisition) indicate a pickup in activity, from extension requests to definitive merger agreements. This suggests the SPAC market is finding a new equilibrium, offering both risks and opportunities for arbitrage.
- Capital Allocation Divergence◆
Companies are taking starkly different approaches to capital. AAR and Summit are using equity and debt for transformative M&A, while News Corp is returning cash via a $1B buyback, and SMFG is paying dividends. This reflects varying stages of corporate lifecycle and market opportunity.
Watch List (7)
-
AstraZeneca's CLARITY-Gastric01 trial results for Claudin18.2-positive gastric cancer are to be presented at ESMO 2026. Positive data could be a major catalyst for the stock.
-
The special meeting to approve the business combination extension is on Oct 13, 2026. The redemption deadline is Oct 8. The outcome will determine if the SPAC liquidates or gets more time to find a deal.
-
The MRO Holdings acquisition is expected to close in AAR's fiscal Q3 (ending Feb 2027). Watch for regulatory approvals and any updates on the financing (debt and PIPE).
-
The FDA will now review the NDA for savolitinib. Watch for acceptance of the filing and a PDUFA date, which will be a key catalyst.
-
Watch for continued production growth and cost reduction in the coming quarters. The company's strategy of holding inventory rather than selling will be key to gauging management's conviction on uranium prices.
-
The company expects to recognize ~$130M in charges during 2027. Watch for updates on the consultation process with works councils and the timeline for the Q1 2027 closure.
-
The company expects to file its delinquent 10-K by Oct 13, 2026. The content of the filing will be critical to assess the severity of its financial and operational issues.
Filing Analyses
(50)
28-09-2026
Redmile Group, LLC and its affiliates disclosed a 8.7% beneficial ownership stake in Electra Therapeutics, Inc., holding 5,462,881 shares of common stock as of September 21, 2026. The filing is a routine Schedule 13G filing by an institutional investment manager, indicating passive investment intent. Redmile Biopharma Investments II, L.P. directly owns 4,796,215 shares, representing 7.6% of the outstanding shares.
- · The filing is made under Rule 13d-1(c), indicating a passive investment intent.
- · Redmile Group, LLC is the investment manager for the Redmile Funds, which directly hold the shares.
- · Jeremy C. Green is the principal of Redmile Group and may be deemed to beneficially own the shares.
- · The percentage ownership is based on 62,766,955 shares outstanding immediately after the IPO, per the issuer's prospectus dated September 17, 2026.
- · The filing includes a joint filing agreement among the reporting persons.
28-09-2026
LSP 7 Cooperatief U.A. and related entities filed a Schedule 13G with the SEC on September 28, 2026, disclosing beneficial ownership of 3,795,281 shares of Electra Therapeutics, Inc. common stock, representing 6.0% of the 62,766,955 shares outstanding as of September 21, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), with LSP 7 Management B.V. and its managing directors disclaiming beneficial ownership. No change in control is intended.
- · Filing date: September 28, 2026; beneficial ownership determined as of September 21, 2026.
- · Reporting Persons include LSP 7 Cooperatief U.A. and LSP 7 Management B.V., organized under Dutch law.
- · LSP 7 Management B.V. is the sole director of LSP 7; managing directors disclaim beneficial ownership.
- · The shares were not acquired for the purpose of changing or influencing control of the issuer.
- · A joint filing agreement was included as Exhibit 1.
28-09-2026
Director Liu Hui exercised/converted 8,482 Common Stock at $7.60 (~$64.5K). 4 transactions reported in total. Liu Hui holds 12,044 shares after the transaction.
- · Director Liu Hui exercised/converted 3,562 Common Stock at $2.38 (~$8.48K)
- · Director Liu Hui exercised/converted 8,482 Common Stock at $7.60 (~$64.5K)
- · Director Liu Hui exercised/converted 3,562 Option (Right to Buy)
- · Director Liu Hui exercised/converted 8,482 Option (Right to Buy) at $5.60 (~$47.5K)
28-09-2026
Chief Financial Officer Hytha David disposed of 4,057 Common Stock. This amends a previously filed Form 4. Hytha David holds 27,047 shares after the transaction.
- · Chief Financial Officer Hytha David disposed of 4,057 Common Stock
28-09-2026
Chief Investment Officer Han Elliot Jin bought 5,000 Common Stock at $4.81 (~$24.1K). This amends a previously filed Form 4. Han Elliot Jin holds 27,047 shares after the transaction.
- · Chief Investment Officer Han Elliot Jin bought 5,000 Common Stock at $4.81 (~$24.1K)
- · Chief Investment Officer Han Elliot Jin disposed of 4,057 Common Stock
28-09-2026
Director Zhao Michael Xu disposed of 23,998 Common Stock. This amends a previously filed Form 4. Zhao Michael Xu holds 159,984 shares after the transaction.
- · Director Zhao Michael Xu disposed of 23,998 Common Stock
29-09-2026
Westlake Corp announced plans to cease operations at its PVC production plant in Cologne, Germany, by Q1 2027, with expected total pre-tax charges of approximately $205 million. The closure will reduce the workforce by about 120 employees, but the company will continue supplying customers from other facilities, including the recently acquired Wilhelmshaven site, to benefit from lower costs. The company also issued a press release providing an update on Q3 2026 financial performance, though specific financial results were not disclosed in this filing.
- · Cessation of operations at the Cologne facility is expected in Q1 2027.
- · Consultations with local works councils initiated on September 29, 2026.
- · Remaining charges (approximately $130 million) expected to be recognized during 2027.
- · Certain cash outflows are expected over several years through completion of the closure.
- · The company will continue supplying customers from other chlorovinyl facilities, including the recently acquired Wilhelmshaven site.
- · The press release furnished as Exhibit 99.1 provides an update on Q3 2026 financial performance, but specific figures were not included in this filing.
29-09-2026
C3is Inc. filed its Form 6-K for the six months ended June 30, 2026, reporting financial results for H1 2026 compared to H1 2025. The filing includes management’s discussion and analysis and consolidated financial statements. No specific financial figures are provided in the cover filing, but the document incorporates prior registration statements on Form S-8 and Form F-3.
- · The filing is incorporated by reference into the Company’s Registration Statement on Form S-8 (Reg. No. 333-273306) filed July 18, 2023 and Registration Statement on Form F-3 (Reg. No. 333-285135) filed February 21, 2025.
- · The report is signed by Chief Financial Officer Nina Pyndiah.
- · The filing date is September 29, 2026, covering the period January 1, 2026 to June 30, 2026.
29-09-2026
ChipMOS Technologies reported strong financial results for August 2026 and Q2 2026, with revenue growing 33.3% YoY in August and 28.7% YoY in the quarter. Net profit attributable to owners surged 117.6% YoY in August and 267.4% YoY in Q2, driven by robust operational performance. No negative or flat metrics were present in the filing.
- · Trailing four quarters (2025Q3-2026Q2) revenue was NT$26,983M, net profit before tax NT$2,675M, and profit attributable to owners NT$2,248M.
- · EPS for the trailing four quarters was NT$3.21.
29-09-2026
Equinor ASA disclosed its daily share buy-back transactions on the Oslo Stock Exchange (OSE) for the week of September 21-25, 2026. The company repurchased a total of 701,262 shares during the week at a weighted average price of NOK 405.97 per share, for a total weekly value of approximately NOK 284.7 million. This brings the accumulated buy-backs under the current tranche to 6,269,053 shares at a total cost of approximately NOK 2.47 billion.
- · All transactions occurred exclusively on the Oslo Stock Exchange (OSE); no activity was reported on CEUX or TQEX.
- · The daily weighted average share price fluctuated between NOK 397.31 and NOK 415.54 during the week.
- · The highest daily volume was 144,493 shares on September 22, while the lowest was 135,769 shares on September 24.
- · Previously disclosed buy-backs under the tranche totaled 5,567,791 shares at a weighted average price of NOK 393.38.
29-09-2026
ING Groep N.V. filed a Form 6-K with the SEC on September 29, 2026, covering the month of September 2026, and incorporated a press release dated September 29, 2026, as Exhibit 99.1. The filing is a routine foreign private issuer report and contains no financial results or operational data.
- · Filing date: September 29, 2026
- · Commission File Number: 001-14642
- · Registrant address: Bijlmerdreef 106, 1102 CT Amsterdam, The Netherlands
- · Exhibit 99.1: Press release dated September 29, 2026
29-09-2026
Liberty Star Uranium & Metals Corp. entered into a Securities Purchase Agreement with Monroe Street Capital Partners LP on September 21, 2026, issuing a convertible promissory note with a principal amount of $95,700. The note carries an 8% interest rate, matures in one year, and includes a 10% original issue discount. This financing provides the company with approximately $86,130 in net proceeds after the OID.
- · The note matures in one year from the date of the agreement (September 21, 2026).
- · The outstanding principal and accrued interest are convertible into shares of the company's common stock.
- · The filing includes exhibits: Convertible Promissory Note (Exhibit 3.89) and Securities Purchase Agreement (Exhibit 3.90).
29-09-2026
HUTCHMED announced the submission of a US New Drug Application (NDA) for ORPATHYS® (savolitinib) in combination with TAGRISSO® (osimertinib) for the treatment of MET-driven EGFR-mutated lung cancer. This regulatory milestone could expand the company's oncology portfolio and address an unmet medical need. However, the filing provides no financial details, and the outcome of the NDA review remains uncertain.
- · The NDA submission is for MET-driven EGFR-mutated lung cancer, a specific patient population.
- · The filing is a Form 6-K for the month of September 2026, with the press release as Exhibit 99.1.
- · The company's principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
29-09-2026
Sangoma Technologies Corporation announced a definitive agreement to be acquired by a wholly owned subsidiary of BRC Group Holdings, Inc. in an all-cash transaction valued at an enterprise value of approximately $204 million (C$289 million). The transaction is expected to close by early 2027.
29-09-2026
United Microelectronics Corporation (UMC) filed a Form 6-K with the SEC on September 29, 2026, as a routine foreign issuer report under the Securities Exchange Act of 1934. The filing was signed by CFO Chitung Liu and includes an exhibit (Exhibit 99.1) but contains no specific financial data, operational updates, or material disclosures.
29-09-2026
Stewards, Inc. (SWRD) filed an 8-K on September 29, 2026, indicating a material agreement entry related to the acquisition of Envy Development PB, LLC, which owns a 214-unit apartment complex in Pompano Beach, Florida. The audited financial statement for the year ended December 31, 2025, shows total revenue of $4,904,596 and revenues in excess of certain operating expenses of $401,447, resulting in a thin margin of approximately 8.2%. The filing includes an emphasis-of-matter paragraph noting the financial statement was prepared solely for SEC compliance and is not a complete presentation of the company's revenues and expenses.
- · The property is a 214-unit residential community located in Pompano Beach, Florida.
- · The financial statement was prepared solely for SEC Rule 3-14 compliance and excludes management fees, depreciation, amortization, and interest.
- · No single tenant comprised over 10% of total revenue in 2025.
- · The company received a $202,030 federal income tax refund subsequent to year-end from a successful property tax challenge.
- · Minimum future lease rentals total $4,479,997, with $4,227,152 due in 2026 and only $252,845 thereafter, indicating most leases expire in 2026.
29-09-2026
On September 25, 2026, Ever Orient International Ltd., Data Bliss Ltd., and Mr. PENG Yongdong sold 5,344,661 ADSs (representing 16,033,983 Class A ordinary shares) of KE Holdings Inc. (BEKE). This disposal reduced the reporting persons' beneficial ownership below 5% of the total outstanding ordinary shares, from a prior 4.7% to below the 5% threshold.
- · The filing is an Amendment No. 1 to a Schedule 13D originally filed on May 30, 2024.
- · The reporting persons previously held 62,824,251 Class A ordinary shares and 94,082,291 Class B ordinary shares.
- · The reporting persons represented that except for the ongoing conversion of Class B ordinary shares to Class A, no other changes occurred from the prior statement.
- · The beneficial ownership calculation treats Class B ordinary shares as converted into Class A for percentage calculation purposes only.
29-09-2026
Ituran Location & Control Ltd. filed its annual report for the year ended December 31, 2025, on Form 20-F with the U.S. SEC. The report includes audited financial statements and the management discussion and analysis. Shareholders can request a free hard copy of the audited financial statements.
- · Registrant files annual reports under Form 20-F (not 40-F).
- · The 6-K is submitted in paper? No (checked as 'No').
- · The filing confirms the annual report for fiscal year ended December 31, 2025, has been furnished to the SEC.
29-09-2026
IperionX Limited filed its Annual Report on Form 6-K with the SEC on September 29, 2026, covering the fiscal year ended June 30, 2026. The filing, signed by CFO Marcela Castro, provides the company's audited financial statements and management discussion for the period. No specific financial figures or operational metrics were disclosed in the filing cover page, limiting quantitative analysis.
- · Filing date: September 29, 2026
- · Commission File Number: 001-41338
- · Principal executive offices: 1092 Confroy Drive, South Boston, Virginia
- · Registrant files annual reports under Form 20-F
- · Exhibit 99.1 contains the Annual Report
29-09-2026
Evotec SE filed a Form 6-K with the SEC on September 29, 2026, announcing a transition in its Chief Scientific Officer role via a press release attached as Exhibit 99.1. The filing provides no financial details or performance metrics, focusing solely on the executive leadership change.
- · The press release announcing the CSO transition was submitted as Exhibit 99.1 to the Form 6-K.
- · The filing was signed by CEO Christian Wojczewski on September 29, 2026.
29-09-2026
Sumitomo Mitsui Financial Group (SMFG) reported strong financial results for FY2026 (year ended March 2026), with operating revenue rising 11.4% YoY to ¥551,827 million and net profit increasing 15.9% to ¥88,933 million. The filing also disclosed the establishment of SMBC Nikko Securities Holdings Establishment Preparatory Company, Inc., a wholly owned subsidiary, which is expected to transition to an intermediate holding company structure on October 1, 2026.
- · Net profit per share for FY2026 was ¥444,663.86, up from ¥383,564.51 in FY2025.
- · The SMBC Nikko Securities Holdings Establishment Preparatory Company was established on April 1, 2005, and is expected to transition to an intermediate holding company structure on October 1, 2026.
- · The Preparatory Company is 100% owned by SMFG and has a capital of ¥10 million.
29-09-2026
Uranium Energy Corp reported fiscal 2026 results, highlighting a transformational year as it became a multi-mine U.S. uranium producer. Fourth quarter production surged 157% QoQ to 82,744 pounds, with total cost per pound down 33% to $36.54, while the unhedged sales strategy delivered a peer-leading realized price of $93.13 per pound. However, full-year production of 229,294 pounds remains modest relative to industry scale, and the company continues to hold most inventory rather than monetizing it, reflecting a strategic bet on further market tightening.
- · UEC has no debt and $753M in liquid assets, including $495M cash.
- · Full-year production of 229,294 pounds is modest; cumulative production since commissioning is 359,260 pounds.
- · UEC sold only 400,000 pounds from inventory in fiscal 2026, holding 1,256,000 pounds in inventory plus 359,260 pounds in-process.
- · Burke Hollow produced 17,352 pounds in its first full quarter, limited to 126 wells in a small section of the first production area.
- · Christensen Ranch produced 65,392 pounds in Q4, with 4 new header houses approved for startup on Sept 28, 2026.
- · Ludeman wellfield construction is underway; satellite ion-exchange plant engineering advanced with long lead-time equipment procured.
- · Sweetwater EA expected March 2027, Plan of Operations approval expected May 2027.
- · Roughrider PFS is progressing with 36,000 meters of core drilling completed.
- · UR&C Class IV cost estimate expected by mid-2027; license application preparation begun.
- · NNSA RFI outlines need for 4 million pounds per year of unobligated U.S.-origin uranium with deliveries as soon as 2030.
- · U.S. Army Janus Program plans more than 20 microreactors requiring unobligated U.S.-origin uranium.
- · UEC had 17 drill rigs in Powder River Basin (up from 12) and 21 in South Texas (up from 8) at year-end.
29-09-2026
Quartzsea Acquisition Corp is seeking shareholder approval to extend its business combination deadline from October 19, 2026 to February 19, 2027, with up to four one-month extensions, each requiring a monthly deposit into the trust account. As of September 22, 2026, the trust holds approximately $74.9 million, and the estimated redemption price is $10.84 per share, while the closing share price was $10.64. If the extension is not approved, the company will liquidate and redeem 100% of public shares. The board recommends voting 'FOR' all proposals.
- · Special Meeting to be held virtually on October 13, 2026 at 4:00 PM Eastern Time.
- · Redemption deadline is October 8, 2026 (two business days before the meeting).
- · Record date for voting is September 22, 2026.
- · If extension not approved, company will cease operations and liquidate by October 19, 2026.
- · Sponsor has agreed not to seek reimbursement from trust account for dissolution expenses.
- · Board retains discretion to abandon proposals even if approved.
- · Shareholders can redeem regardless of how they vote or whether they vote.
- · Proxy materials available at https://www.cstproxy.com/quartzsea/ext2026.
29-09-2026
TurnOnGreen, Inc. filed an 8-K on September 29, 2026, disclosing the adoption of new Bylaws effective September 25, 2026. The Bylaws govern corporate governance, including shareholder meetings, director powers, officer roles, and indemnification provisions. The filing is a routine governance update with no financial impact disclosed.
- · The Bylaws were adopted by the Board of Directors effective September 25, 2026.
- · Shareholders holding more than 20% of voting power can call special meetings.
- · Shareholders do not have cumulative voting rights for director elections.
- · The Bylaws include provisions for indemnification of directors and officers.
- · The Bylaws specify a forum selection clause for shareholder disputes.
29-09-2026
Singularity Future Technology Ltd. (SGLY) filed a Form NT 10-K late-filing notice on September 29, 2026, indicating it could not file its Annual Report on Form 10-K for the fiscal year ended June 30, 2026 by the September 28, 2026 deadline. The delay is attributed to the company's inability to finalize financial statements and disclosures without unreasonable effort or expense. The company expects to file the Annual Report by October 13, 2026, the fifteenth calendar day after the prescribed due date, and has confirmed that no significant change in results of operations is anticipated.
- · Filing deadline was September 28, 2026; extension filed under Rule 12b-25.
- · Anticipated filing date for the Annual Report is October 13, 2026 (15th calendar day after due date).
- · Registrant confirmed all other required periodic reports for the preceding 12 months have been filed.
- · No significant change in results of operations is anticipated compared to the prior fiscal year.
- · Contact person: Jia Yang, CEO, (702) 849-4548.
29-09-2026
Nova Minerals Corp filed a Form NT 10-K on September 29, 2026, indicating it will be unable to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2026 by the prescribed due date. The delay is attributed to the need for additional time to compile, review, and finalize financial statement data, disclosures, and accounting policies following the company's redomicile to the U.S. in June 2026. The company expects to file the report within the 15-day grace period provided by Rule 12b-25 and does not anticipate any significant change in results of operations from the prior fiscal year.
- · The filing is for the fiscal year ended June 30, 2026.
- · The company redomiciled to the U.S. in June 2026, making this its inaugural period filing as a U.S. entity.
- · The company has filed all other periodic reports required under the Exchange Act during the preceding 12 months.
- · The company does not anticipate any significant change in results of operations from the prior fiscal year.
- · The notification was signed by CFO Ashlie Thorburn on September 28, 2026.
29-09-2026
Bitari Inc. has filed an S-1/A registration statement for its initial public offering. The filing warns that the company faces significant risk of failing to meet Nasdaq's new, stricter listing requirements, which include a minimum public float of $15 million and expanded discretionary denial authority. Additionally, the company will be a 'controlled company' with AI Power X Inc. holding 85.87% of shares (assuming no over-allotment exercise), giving Ms. Pei Zhao dominant voting power, and it plans to take advantage of reduced reporting obligations under the JOBS Act as an emerging growth company and smaller reporting company.
- · Bitari Inc. will rely on certain exemptions applicable to 'emerging growth company' and 'smaller reporting company' status under the JOBS Act.
- · The company has elected to use the extended transition period for complying with new or revised accounting standards.
- · Upon completion of the offering, AI Power X Inc. will hold 85.87% of the outstanding shares (no over-allotment), giving Ms. Pei Zhao dominant control.
- · Nasdaq may deny initial listing even if quantitative requirements are met, under new Rule IM-5101-3 effective December 19, 2025.
- · The company's auditors will not be required to attest to the effectiveness of internal controls over financial reporting as long as it remains a smaller reporting company.
29-09-2026
Summit Therapeutics announced a $2.0 billion strategic equity investment from AstraZeneca in convertible preferred shares, priced at $18.36 per common share (a premium to the closing price), alongside a clinical trial collaboration to evaluate ivonescimab with AstraZeneca's ADC sonesitatug vedotin in gastrointestinal cancers and a non-binding MOU for broader ADC combinations. The investment and collaboration validate ivonescimab's potential, but the MOU is non-binding with no assurance of fruition, and ivonescimab remains unapproved in Summit's license territories. Summit's Phase III program shows positive readouts across five trials, yet the company faces regulatory and clinical execution risks.
- · Ivonescimab is not approved by any regulatory authority in Summit's license territories, including the US and Europe.
- · The MOU for the broader clinical trial collaboration is non-binding, with no assurances of fruition.
- · AstraZeneca's CLARITY-Gastric01 trial showed statistically significant OS improvement in 2nd/later-line Claudin18.2-positive advanced gastric cancer; results to be presented at ESMO 2026.
- · HARMONi-GI1 (Akeso-sponsored) showed statistically significant OS benefit in advanced BTC; HARMONi-GI3 is a Phase III trial in first-line metastatic CRC.
- · HARMONi-GU1 is a Phase II/III study in urothelial carcinoma with global site activations planned by Q4 2026.
- · Summit's BLA for ivonescimab was accepted by the FDA with a PDUFA date of November 14, 2026.
- · Ivonescimab has a half-life of 6-7 days after first dose, increasing to ~10 days at steady state.
- · Akeso reported positive OS benefits in HARMONi-A, HARMONi-2, HARMONi-6 (NSCLC) and HARMONi-GI1 (BTC) in China.
29-09-2026
Uranium Energy Corp (UEC) reported fiscal 2026 total sales and service revenue of $37.25 million, down 44% from $66.84 million in fiscal 2025, while net loss widened to $137.31 million from $87.66 million. The company significantly strengthened its balance sheet, with cash and cash equivalents rising to $495.46 million from $148.93 million, and working capital more than doubling to $547.61 million. However, production costs per pound increased, with total cash cost per pound rising to $34.24 from $27.63, and the company continued to invest heavily in growth, deploying $171.29 million in growth capital.
- · Quarterly revenue was highly volatile: Q1 FY2026 (Oct 2025) $0, Q2 FY2026 (Jan 2026) $20.2M, Q3 FY2026 (Apr 2026) $0, Q4 FY2026 (Jul 2026) $17.05M.
- · Quarterly net losses increased sequentially: Q1 FY2026 $10.34M, Q2 FY2026 $13.94M, Q3 FY2026 $52.34M, Q4 FY2026 $60.69M.
- · Total assets grew to $1.51 billion as of July 31, 2026, up from $1.11 billion a year earlier.
- · Adjusted EBITDA was negative $118.11 million in FY2026, compared to negative $62.83 million in FY2025.
- · Mineral property development expenditures more than doubled to $57.80 million in FY2026 from $33.89 million in FY2025.
- · Exploration expenditures more than doubled to $23.23 million in FY2026 from $11.14 million in FY2025.
- · The company recorded a $17.51 million fair value loss on equity securities in FY2026, compared to an $18.05 million loss in FY2025.
- · Interest income increased to $15.58 million in FY2026 from $4.02 million in FY2025.
29-09-2026
Bakhu Holdings reported a net loss of $(483,981) for the three months ended April 30, 2025, a significant improvement from a net loss of $(906,837) in the prior-year period, driven by lower operating expenses. However, the company had no revenue, cash and cash equivalents fell sharply to $2,041 from $25,461, and total liabilities increased to $11,796,135, reflecting continued financial distress.
- · Net cash used in operating activities improved to $(40,676) for the nine months ended April 30, 2025, from $(1,065,382) in the prior-year period.
- · Stock-based compensation decreased to $1,073,292 for the nine months ended April 30, 2025, from $1,256,951 in the prior-year period.
- · Interest expense increased to $324,666 for the nine months ended April 30, 2025, from $229,555 in the prior-year period.
- · The company had no revenue in either period.
- · Total stockholders' deficit widened to $(11,794,094) at April 30, 2025, from $(11,011,550) at July 31, 2024.
- · Options outstanding decreased by 300,000 due to expiration, from 9,058,085 to 8,758,085.
29-09-2026
VerifyMe, Inc. is pursuing a merger with Open World Ltd., a Cayman Islands company, via a merger agreement entered on February 11, 2026. The filing provides pro forma financial information for the six months ended June 30, 2026, and includes audited financial statements of OpenWorld for 2025 and 2024. Stockholder approval was obtained on September 24, 2026, but the transaction remains subject to other closing conditions and regulatory approvals.
- · The merger agreement was entered on February 11, 2026.
- · The Registration Statement was declared effective by the SEC on August 12, 2026.
- · Stockholders approved the merger proposals on September 24, 2026.
- · The filing includes audited financial statements of OpenWorld for years ended Dec 31, 2025 and 2024, and unaudited statements for the six months ended June 30, 2026 and 2025.
- · Pro forma condensed combined financial information for VerifyMe and OpenWorld as of and for the six months ended June 30, 2026 is provided.
29-09-2026
VerifyMe, Inc. filed an 8-K providing pro forma financial information for its proposed merger with Open World Ltd., which was approved by stockholders on September 24, 2026. The filing includes audited financial statements of OpenWorld for 2024 and 2025, unaudited interim statements for the six months ended June 30, 2026, and pro forma combined financials. No specific financial figures are disclosed in the filing text, so performance trends cannot be assessed from this document alone.
- · Stockholders approved the merger proposals on September 24, 2026.
- · The Registration Statement was declared effective by the SEC on August 12, 2026.
- · Audited financial statements of OpenWorld for years ended December 31, 2025 and 2024 are included as Exhibit 99.1.
- · Unaudited pro forma combined financial information for VerifyMe and OpenWorld as of and for the six months ended June 30, 2026 is included as Exhibit 99.3.
29-09-2026
HUTCHMED (China) Limited has initiated a global trial of HMPL-A830, a novel KRAS-EGFR-antibody conjugate therapy, in patients with solid tumors. The trial is a significant step in the company's oncology pipeline, though no financial figures or prior-period comparisons are provided in this filing.
- · The trial is global in scope and targets patients with solid tumors.
- · HMPL-A830 is a KRAS-EGFR-antibody conjugate therapy, a novel approach combining two targets.
29-09-2026
Futurewave Acquisition Corp (FWAC) entered into a definitive merger agreement to acquire Olympian Group Inc. in a transaction valuing the company at $400 million. The deal will be effected through a reincorporation merger and an acquisition merger, with Olympian shareholders receiving 40,000,000 Purchaser ordinary shares valued at $10.00 per share. The transaction is subject to shareholder approvals, SEC effectiveness, and other customary closing conditions, with a termination date of June 26, 2027.
- · The Merger Agreement includes a termination date of June 26, 2027, which may be extended.
- · The Company will provide loans up to $1.6 million to the Sponsor in tranches tied to deal milestones.
- · Each Purchaser Class A ordinary share carries one vote, while each Purchaser Class B ordinary share carries ten votes and is convertible into Class A shares.
- · The board of directors of Purchaser will consist of five directors: one independent director appointed by Parent and four directors appointed by the Company.
- · The Merger Agreement may be terminated by either party if the other party causes a delay in the business combination process exceeding six months, subject to exceptions for regulatory approvals.
- · Representations and warranties of the parties will not survive the closing.
29-09-2026
Futurewave Acquisition Corporation (Nasdaq: FWAC), a SPAC, announced a definitive merger agreement with Olympian Group Inc., a Cayman Islands holding company of HK Shang Ge Industrial Limited, which provides integrated chip and electronic component solutions in Hong Kong. The combined company is expected to be Nasdaq-listed, with Olympian shareholders receiving 40,000,000 Purchaser ordinary shares valued at $10.00 per share, based on a Company Net Value of $400,000,000. The transaction is subject to customary closing conditions, including regulatory and shareholder approvals, and no financial performance data for either entity is disclosed in this filing.
- · Futurewave is a Cayman Islands SPAC with units, ordinary shares, warrants, and rights listed on Nasdaq under symbols FWACU, FWAC, FWACW, and FWACR.
- · Olympian operates through its wholly owned Hong Kong subsidiary, HK Shang Ge Industrial Limited.
- · Olympian's business model is vertically oriented, focusing on integrated electronic component solutions for automotive electronics and industrial connectivity sectors.
- · Each Purchaser Class A ordinary share carries one vote; each Purchaser Class B ordinary share carries ten votes and is convertible into one Class A share at the holder's option.
- · Lock-up restrictions on Olympian key founder shares expire the earlier of six months after closing or when the closing price of Purchaser Class A ordinary shares equals or exceeds $12.50 per share for 20 trading days within any 30-trading-day period.
- · The Merger Agreement is dated September 28, 2026, and the filing was made on September 29, 2026.
- · No financial performance data (revenue, profit, growth rates) for Futurewave or Olympian is disclosed in this filing.
29-09-2026
WeShop Holdings Ltd filed an F-1 registration statement with the SEC for a proposed IPO of Class A ordinary shares. The company, a BVI business incorporated in 2021 via a SPAC acquisition, has never paid dividends and will not receive proceeds from the selling shareholders. As of June 30, 2026, the company had cash of £210,565, total indebtedness of £2,771,947, and an accumulated deficit of £153,159,969, resulting in total shareholders' equity of £5,459,534.
- · The company was initially formed as Boanerges Limited, a SPAC listed on Aquis on April 23, 2021, and renamed to WeShop Holdings Limited after acquiring WeShop Limited on November 17, 2021.
- · Principal executive offices are in Jersey, Channel Islands.
- · The company qualifies as a foreign private issuer and an emerging growth company, allowing exemptions from certain U.S. corporate governance and executive compensation rules.
- · The company has never paid or declared any cash dividends and does not anticipate doing so in the foreseeable future.
- · As of June 30, 2026, the company had notes payable of £196,497, loans payable of £100,000, loans payable – related party of £2,266,666, accrued interest of £31,120, and accrued interest – related parties of £177,664.
- · Paul Ellerbeck is the sole director of CSIL, which holds approximately 19% of the company's Class A ordinary shares.
- · The company will not receive any proceeds from the sale of shares by the Selling Shareholders.
29-09-2026
WeShop Holdings Ltd filed an F-1 registration statement with the SEC for its initial public offering, outlining plans to expand into the U.S. market and raise capital through a committed equity facility with Roth Principal Investments. As of September 24, 2026, the company has awarded approximately 1.16 million WePoints to users (virtually all in the UK) but none have been redeemed for Class A ordinary shares. The filing highlights significant risks, including the need for substantial additional financing to continue as a going concern and reliance on a limited number of affiliate network partners.
- · The company's Pilot ran from July 2022 to November 2024 in the United Kingdom.
- · Shareback Rates are expected to generally fall within 40% to 80% of the commission received from affiliate networks.
- · WeShop holds registered trademarks in the UK, EU, US, and selected international territories for key brands.
- · The filing includes a 'going concern' risk and states the company requires substantial additional financing to support growth.
- · Forward-looking statements include risks related to competition, management of growth, and potential fluctuations in operating results.
29-09-2026
Korn Ferry held its 2026 Annual Meeting on September 24, 2026, where stockholders approved the Amended and Restated 2022 Stock Incentive Plan, increasing available shares by 1,400,000 and extending the plan term to September 24, 2036. All nine director nominees were elected, and the advisory executive compensation resolution, the Plan, and the ratification of Ernst & Young LLP as independent auditor were approved. The company also disclosed the Plan's adoption by the Board on August 4, 2026, subject to stockholder approval.
- · The Plan extends the term to September 24, 2036.
- · The Plan revises the non-employee director compensation limit to an annual cash limit instead of an annual share limit.
- · The Plan was approved by stockholders with 43,102,365 votes for, 2,155,490 against, and 24,204 abstentions.
- · The advisory executive compensation resolution received 43,800,129 votes for, 1,145,915 against, and 336,015 abstentions.
- · The ratification of Ernst & Young LLP received 46,296,359 votes for, 1,349,716 against, and 30,086 abstentions.
- · Broker non-votes were 2,394,102 for all director elections and the compensation and Plan matters.
- · The 2026 Annual Meeting was held on September 24, 2026.
- · The Board unanimously adopted the Plan on August 4, 2026, subject to stockholder approval.
29-09-2026
AAR CORP. announced a definitive agreement to acquire a 65% controlling interest in MRO Holdings at an implied enterprise value of $4.0 billion, significantly enhancing its aftermarket platform scale, margins, and cash flow. The acquisition adds over $1 billion in revenue from blue-chip U.S. airline customers and is expected to expand AAR's consolidated adjusted EBITDA margins from approximately 12% to 16% before synergies, with a target of 19% to 20% within three to four years. The transaction is expected to close in AAR's fiscal third quarter ending February 2027 and will be funded through approximately $2.1 billion of new debt, $780 million of equity issued to MRO Holdings shareholders, and $230 million from a PIPE offering.
- · AAR will have the option to acquire the remaining 35% of MRO Holdings in tranches: 5% at any time within six years, and 30% in three equal 10% tranches on the second, third, and fourth anniversaries of closing.
- · AAR expects net leverage to return to its target range of 2.0x to 2.5x over the medium term.
- · AAR expects to maintain its BB-category credit rating profile at S&P and Moody's.
- · The transaction is expected to close in AAR's fiscal third quarter ending February 2027.
- · AAR will receive 100% of the excess cash flow from MRO Holdings during the first two years of ownership.
- · MRO Holdings operates facilities in El Salvador, Mexico, Colombia, and the United States.
- · Approximately 90% of MRO Holdings' revenue is from U.S. customers.
- · AAR's Board of Directors has unanimously approved the transaction.
29-09-2026
Westin Acquisition Corp filed its Form 10-K for the fiscal year ended June 30, 2026, reporting a net income of $890,446 compared to a net loss of $9,475 in the prior period (June 3, 2025 inception through June 30, 2025). The company held $58.88 million in trust as of June 30, 2026, with total assets of $59.20 million, but also reported that accretion of redeemable shares to redemption value resulted in a net loss including accretion of $3.92 million. Operating cash flow was negative ($330,991), and the company remains a blank-check entity seeking an initial business combination, with no target identified and ongoing risks around liquidity and deal completion.
- · Total operating expenses for fiscal 2026 were $490,333, consisting of $478,565 in administrative fees and $11,768 in formation costs.
- · Income earned on marketable securities held in trust was $1,380,779 for fiscal 2026.
- · Deferred offering costs of $200,000 were recorded as of June 30, 2025 (no assets in trust at that date).
- · Net cash provided by financing activities was $58,150,000, driven by public offering proceeds and private placement.
- · Weighted average redeemable ordinary shares outstanding: 3,733,562; basic/diluted EPS on redeemable shares: $0.63.
- · Weighted average non-redeemable ordinary shares outstanding: 2,202,425; basic/diluted loss per share on non-redeemable shares: ($0.66).
29-09-2026
Julong Holding Ltd raised gross proceeds of US$897,750 through a private placement on September 28, 2026, issuing 750,000 Class A ordinary shares at US$0.300 per share and 2,250,000 pre-funded warrants at US$0.299 per warrant. Net proceeds after expenses are approximately US$828,000, which will be used for general corporate purposes. The filing is a routine disclosure of a capital-raising transaction and does not contain any negative or flat performance metrics.
- · The private placement is exempt from SEC registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
- · Purchasers represented they were accredited investors acquiring securities for investment only.
- · The filing incorporates by reference the company's Form F-3 registration statement (File No. 333-297664).
- · The pre-funded warrants are immediately exercisable at US$0.001 per share until exercised in full.
29-09-2026
Quantum-Si Incorporated filed an 8-K on September 28, 2026, announcing a press release and a presentation to be delivered at World HUPO 2026 in Singapore on September 29, 2026. The presentation provides updates on the company's business and is available on the company's investor relations website. The filing is a routine Regulation FD disclosure and does not contain any financial results or material quantitative data.
- · The presentation was posted on the company's website and furnished as Exhibit 99.1 to the 8-K.
- · The press release was issued on September 28, 2026, and is included as Exhibit 99.2.
- · The presentation was scheduled for September 29, 2026 at 12:15 p.m. SGT at World HUPO 2026 in Singapore.
29-09-2026
Copart Inc. filed its Form 10-K for fiscal year ended July 31, 2026, reporting total service revenues of $3,969,520 thousand, essentially flat (+0.0%) versus the prior year, while total vehicle sales grew 2.7% to $696,689 thousand. Net income margin declined slightly to 32% of revenue from 33% in 2025. The company's cash position fell sharply by 31.4% to $1,907,901 thousand, and working capital decreased 4.1%.
- · Net income margin declined to 32% of total revenue in FY2026 from 33% in FY2025, while income before income taxes remained at 40%.
- · Operating income margin remained flat at 36% of total revenue in FY2026 and FY2025.
- · Total operating expenses as a percentage of revenue remained at 64% in FY2026 and FY2025.
- · Cost of vehicle sales as a percentage of revenue remained at 13% in FY2026 and FY2025.
- · General and administrative expenses as a percentage of revenue remained at 9% in FY2026 and FY2025.
- · Income tax expense as a percentage of revenue increased to 8% in FY2026 from 7% in FY2025.
29-09-2026
New Pacific Metals Corp. has announced its Annual General Meeting (AGM) will be held on November 27, 2026, in Vancouver, BC. The record date for notice, voting, and beneficial ownership determination is October 23, 2026. The filing is a routine procedural notice with no financial results or operational updates.
- · The company files under Form 40-F, not Form 20-F.
- · The meeting will be held in Vancouver, BC.
- · The issuer is not sending proxy materials directly to NOBO and is not paying for delivery to OBO.
- · Notice and Access requirements are not applicable for either beneficial or registered holders.
- · Voting security details: Common Class, CUSIP 64782A107, ISIN CA64782A1075.
29-09-2026
Orion Digital Corp. (formerly Mogo Inc.) filed a Form 6-K with the SEC on September 29, 2026, announcing it has regained compliance with Nasdaq's minimum bid price requirement. The filing includes a press release dated September 28, 2026, as Exhibit 99.1. No financial results or period-over-period comparisons are provided in this filing.
- · Company name changed from Mogo Inc. to Orion Digital Corp.
- · Regained compliance with Nasdaq's minimum bid price requirement as of September 28, 2026.
- · Press release dated September 28, 2026, is attached as Exhibit 99.1.
29-09-2026
VIP Play, Inc. filed its 10-K annual report for the fiscal year ended June 30, 2026, reporting a net loss of $9,516 (thousand) compared to a net loss of $19,159 (thousand) in the prior year, a significant improvement. However, the company continues to operate with negative gaming margins, a deeply negative stockholders' deficit of $(39,951) (thousand), and total liabilities of $42,228 (thousand) against total assets of only $2,277 (thousand).
- · The company's accumulated deficit grew to $(72.644M) as of June 30, 2026, from $(63.128M) a year earlier.
- · Total stockholders' deficit worsened to $(39.951M) from $(31.774M).
- · Cash reserves for users dropped to zero from $277K, and players' balances also fell to zero from $336K, suggesting a cessation of user-facing operations.
- · Intangible assets were fully impaired to zero from $883K.
- · The company's line of credit from a related party increased 52.3% to $29.831M, and accrued expenses to related parties more than doubled to $5.041M.
- · Derivative liability decreased 50.5% to $5.553M, while convertible notes decreased 47.2% to $437K.
- · The company's net gaming loss increased 74.7% to $(1.041M), despite gaming revenue turning positive.
- · Sales and marketing expenses were cut by 48.2% to $590K, while general and administrative expenses rose 47.0% to $3.791M.
- · The company's dividend policy prohibits distributions if total assets would be less than total liabilities plus preferential rights.
- · Two different PCAOB-registered audit firms are listed: Frank, Rimerman + Co. LLP and Grassi & Co., CPAs, P.C.
29-09-2026
Grupo Aval Acciones y Valores S.A. announced the payment of interest on its Sixth Issuance of Notes (denominated in Colombian Pesos) on September 28, 2026, as per the terms of the offering memorandum. The filing is a routine disclosure of a scheduled debt service obligation with no new financial or operational data provided.
- · The interest payment relates to the Sixth Issuance of Notes made in Colombian Pesos in the local market.
- · No principal repayment or default was mentioned; only interest was paid.
- · No financial figures (e.g., amount paid, interest rate, outstanding balance) were disclosed in the filing.
29-09-2026
News Corp filed an 8-K on September 29, 2026, disclosing its ongoing stock repurchase program, under which it is authorized to buy back up to $1 billion in aggregate of its Class A and Class B common stock. The filing includes daily transaction disclosures provided to the Australian Securities Exchange (ASX) as required by ASX rules. No specific repurchase activity or financial results were reported in this filing.
- · The repurchase program covers both Class A Common Stock (ticker: NWSA) and Class B Common Stock (ticker: NWS), each with a par value of $0.01 per share.
- · The Company is required to provide daily transaction disclosures to the ASX under ASX rules.
- · The filing includes forward-looking statements regarding the Company's intent to repurchase shares from time to time, subject to market conditions, securities laws, and alternative investment opportunities.
29-09-2026
Largo Inc., a Canadian vanadium producer, filed a Form 6-K with the SEC on September 29, 2026, incorporating by reference exhibits related to a securities purchase agreement, common warrant, and placement agent warrant. The filing includes legal opinions and a press release dated September 25, 2026, suggesting a planned securities offering.
- · The filing incorporates exhibits for legal opinions from Stikeman Elliot LLP and Troutman Pepper Locke LLP.
- · Exhibits include forms of Securities Purchase Agreement, Common Warrant, and Placement Agent Warrant.
- · A press release dated September 25, 2026 is included as Exhibit 99.6.
Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →October 01, 2026
Significant Contract Modifications ($10M+) — October 01, 2026
Significant Contract Modifications ($10M+)
October 01, 2026
HHS & Healthcare Contracts Intelligence — October 01, 2026
HHS & Healthcare Contracts Intelligence
October 01, 2026
New Federal Contractors — October 01, 2026
New Federal Contractors
October 01, 2026
US Merger & Acquisition SEC Filings — October 01, 2026
US Merger & Acquisition SEC Filings